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Abstract
Background: Potentiating the effect of intrathecal local anesthetics by addition of intrathecal
opiods for intra-abdominal surgeries is known. In this study by addition of fentanyl we tried to
minimize the dose of bupivacaine, thereby reducing the side effects caused by higher doses of
intrathecal bupivacaine in cesarean section.
Methods: Study was performed on 120 cesarean section parturients divided into six groups,
identified as B8, B10 and B 12.5 8.10 and 12.5 mg of bupivacaine mg and FB8, FB10 and FB 12.5 received
a combination of 12.5 µg intrathecal fentanyl respectively. The parameters taken into consideration
were visceral pain, hemodynamic stability, intraoperative sedation, intraoperative and
postoperative shivering, and postoperative pain.
Results: Onset of sensory block to T6 occurred faster with increasing bupivacaine doses in
bupivacaine only groups and bupivacaine -fentanyl combination groups. Alone lower concentrations
of bupivacaine could not complete removed the visceral pain. Blood pressure declined with the
increasing concentration of Bupivacaine and Fentanyl. Incidence of nausea and shivering reduces
significantly whereas, the postoperative pain relief and hemodynamics increased by adding fentanyl.
Pruritis, maternal respiratory depression and changes in Apgar score of babies do not occur with
fentanyl.
Conclusion: Spinal anesthesia among the neuraxial blocks in obstetric patients needs strict dose
calculations because minimal dose changes, complications and side effects arise, providing impetus
for this study. Here the synergistic, potentiating effect of fentanyl (an opiod) on bupivacaine (a local
anesthetic) in spinal anesthesia for cesarian section is presented, fentanyl is able to reduce the dose
of bupivacaine and therefore its harmful effects.
Background
Spinal anesthesia is the preferred means for cesarean sec-
tion, being simple to perform, economical and produces
rapid onset of anesthesia and complete muscle relaxation.
It carries high efficiency, involves less drug doses, minimal
neonatal depression, awake mother and lesser incidences
of aspiration pneumonitis. However, it also produces a
fixed duration of anesthesia, postdural puncture, head-
ache, hypotension and lesser control of block height [1].
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Bupivacaine, an amide type of local anesthetic, has high
potency, slow onset (5–8 minutes) and long duration of
action (1.5–2 hours). For cesarean section intrathecal
dose of hyperbaric bupivacaine is 12 to 15 mg [2]. Cesar-
ean delivery requires traction of peritoneum and handling
of intraperitoneal organs, resulting in intraoperative vis-
ceral pain. With higher doses of hyperbaric bupivacaine,
incidence of intraoperative visceral pain associated with
higher blocks [4] is reduced [3].
Opiods have been a choice in regional (intrathecal and
epidural routes) anesthesia to improve the antinocicep-
tive effect of local anesthetics. Morphine [5], and fentanyl
[6], are being used intrathecally, together with local anes-
thetics in cesarean section.
This study aims to monitor the effect of intrathecal fenta-
nyl + bupivacaine on reduction of higher blocks incidence
simultaneously improving the quality and avoiding the
complications of higher doses of local anesthetics used in
spinal anesthesia in cesarean section. The study can be
implicated to select the best possible combination of local
anesthetics used in spinal anesthesia in cesarean section.
Methods
The study was cleared from the Ethics Committee of the
University and written consent was taken from patients
who participated in this study. All the patients taken for
this study belonged to American Society of Anesthesiol-
ogy (ASA) grade 1 or 2. None of the patients had any con-
tradiction for spinal anesthesia. Complicated pregnancies
such as multiple pregnancies, pregnancy induced hyper-
tension and placenta previa were excluded. Also the ante-
natal patients with acute fetal distress were excluded,
keeping the respiratory depressant effect of fentanyl in
mind.
Prospective single-blind study was performed on 120 par-
turients. In the first group of 60 parturients we tried to
find the optimal dose of intrathecal bupivacaine, which
was not associated with visceral pain. In the second group
of 60 parturients intrathecal fentanyl was added to varying
dose of bupivacaine. The second group was made with the
idea to find out the lowest dose of bupivacaine-fentanyl
combination that was not associated with visceral pain.
The first group of 60 parturients was further subdivided
into 3 subgroups receiving 8,10 or 12.5 mg of 0.5% hyper-
baric intrathetal bupivacaine respectively. The second
group also of 60 parturients was again subdivided into 3
subgroups receiving 8,10 or 12.5 mg of 0.5% hyperbaric
intrathetal bupivacaine mixed with 12.5 µg of intrathecal
fentanyl. All parturients were given rapid fluid infusion of
1 to 1.5 litres ringer lactate via 18 gauge venous catheter.
Spinal anesthesia was given in lateral position. For lumbar
puncture 25 gauge needle was used. Immediately after the
block each parturient was placed with 10 cm wedge under
right hip. Pulse and noninvasive blood pressure were
measured every 5 minutes for the first 30 minutes and
thereafter every 10 minutes. If the systolic blood pressure
fell below 90 mm HG, additional vasopressor support was
given.
Sensory block was tested by pinprick at the left midclavic-
ular line till the block reached T6 when the surgical inci-
sion will be allowed. Degree of motor block was assessed
by using Bromage scale (BS).
Intraoperative pain was checked whenever the parturients
complained of discomfort or pain during operation and
expressed as visual analogue scale (VAS 0–1000 mm) by
the parturient. Each time VAS exceeded 30–50 µg fentanyl
was given IV.
Muscle relaxation was assessed clinically and rated as
poor, fair, good or excellent and score of 1,2,3 or 4 was
given for each description respectively.
Incidence of nausea, vomiting, itching, shivering pruritus
and sedation during operation, the time required for sen-
sory recovery to T10, motor recovery to B0 and the onset
of postoperative pain was recorded. All these time varia-
bles were measured from the beginning of the spinal
injection. Apgar score of all the babies at 1, 5 and 10 min-
utes and maternal depression were also recorded.
Results
The study was performed on 120 parturients undergoing
caesarian section under spinal anesthesia. Six group of
twenty each were made as follows according to the
intrathecal medication.
Group I-B8 (8 mg 0.5% hyperbaric bupivacaine)
Group II-B10 (10 mg 0.5% hyperbaric bupivacaine)
Group III-B 12.5 (12.5 mg 0.5% hyperbaric bupivacaine)
Group IV-FB8 (8 mg 0.5% hyperbaric bupivacaine+12.5
µg fentanyl)
Group V-FB10 (10 mg 0.5% hyperbaric bupivacaine +12.5
µg fentanyl)
Group VI-FB 12.5 (12.5 mg 0.5% hyperbaric bupivacaine
+12.5 µg fentanyl)
All six groups were almost of similar age (30 ± 4 years),
height (158 ± 6 cm) and weight (54 ± 11 kg).BMC Anesthesiology 2005, 5:5 http://www.biomedcentral.com/1471-2253/5/5
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Onset of sensory block to T6 occurs faster with increasing
bupivacaine doses in the alone or < combination groups
with fentanyl. Muscle relaxation (degree of muscle relaxa-
tion i.e. 4) was excellent in all the patients of all the
groups. About 90–100% parturients had complete motor
block, with no significant change in different groups. No
visceral pain was noticed in any of the combination
treated group as well as Group III receiving 12.5 mg of
bupivacaine. Incidence of visceral pain was significantly
higher in B8 and B10.
Maximum fall in the systolic blood pressure was noticed
after 25 minutes in all the groups. Depending upon the %
of systolic blood pressure fall the following series can be
Alterations in different clinical profiles of six groups Figure 1
Alterations in different clinical profiles of six groups
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drawn: FB 12.5>B 12.5>FB10>B10>FB8>B8. On comparing the
hemodynamic stability of equipotent dose of bupivacaine
and bupivacaine-fentanyl, we found that the later is more
stable. We found the intraoperative hypotension increases
with increasing doses of bupivacaine however, alongwith
fentanyl it increased more. Bradycardia was found in 10–
15% cases in each group. There exists no statistical signif-
icance in the incidence of Bradycardia in different groups.
There was no intraoperative sedation in bupivacaine
whereas 75–90% of parturient of bupivacaine-fentanyl
combination groups were drowsy but arousable. Inci-
dence of vomiting was more in bupivacaine alone group
than in combination. Duration of post-operative analge-
sia increased with increasing dose of bupivacaine. Also
addition of fentanyl to bupivacaine increased the postop-
erative analgesic effect. Motor recovery takes longer with
Alteration in different clinical syptoms in 6 groups Figure 2
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increasing doses of bupivacaine alone or in combination
with fentanyl. Data of the above-mentioned clinical
parameters (if they are significantly different from each
other) are given in Fig. 1 and 2.
Apgar score (9.85 ± 0.37 at 10 minutes) of babies was
unaffected when additive of 12.5 µg of intrathecal fenta-
nyl was used in cesarean section.
Discussion
Recent trends of obstetric anesthesia show increased pop-
ularity of regional anesthesia amongst obstetric anesthet-
ists. General anesthesia is associated with higher mortality
rate in comparison to regional anesthesia. However,
regional anesthesia is not without risk. Deaths in regional
anesthesia are primarily related to excessive high regional
blocks and toxicity of local anesthetics. Reduction in
doses and improvement in technique to avoid higher
block levels and heightened awareness to the toxicity of
local anesthetics have contributed to the reduction of
complications related with regional anesthesia [7]. Spinal
anesthesia among the neuraxial blocks in obstetric
patients needs more strict dose calculations as the drugs
are directly injected in intrathecal space. With minimum
dose changes, the chances of complications and side
effects are enhanced [1]. Above-mentioned factors pro-
vided us the impetus to perform this study.
These days 0.5% heavy bupivacaine is used commonly for
spinal and epidural anesthesia. It was decided to combine
it with intrathecal fentanyl to provide adequate depth of
anesthesia with lesser doses of bupivacaine [8]. Fentanyl
is a lipophilic opiod and is preferred for having a rapid
onset and short duration of action with lesser incidence of
respiratory depressions. Our results of onset time of sen-
sory block to T6 corroborrate with that of Randalls et. al
(1991) [9] which state that the onset of sensory block to
T4 gets faster with increasing bupivacaine doses, whereas,
it differs from the observations of Singh et. al (19 95) [10].
Complete motor block was achieved in 90–100% of
patients with our study; this is in accordance with the
results of Pederson et.al (1989) [3] and Choi et.al (2000)
[2]. Visceral pain is a common problem in cesarean sec-
tion under spinal anesthesia. In our study we found no
pain in B 12.5 group however, visceral pain was not fully
abolished with lower doses of bupivacaine. Our results
corroborates fully with Choi et.al (2000) [2].
It is evident from the results that the depth of anesthesia
in FB8 group is equivalent to B 12.5 group. This proves that
by adding fentanyl adequate depth of spinal anesthesia
can be achieved at much lower doses of bupivacaine. Inci-
dence of hypotension as well as fall in the systolic BP
increases with the dose of bupivacaine. However, no sig-
nificant difference was noticed in the fentanyl added
group when compared with their nonadded counterpart.
Bradycardia results from the blockade of sympathetic car-
dio accelerator fibers and decreased venous return to the
heart. In our study bradycardia occurrence was overall 7%
with no significant intergroup variation. This is in accord-
ance with Singh et.al (1991) [10]. About 75–90% of the
patients become drowsy but arousable with the
intrathecal fentanyl addition as compared to those with-
out fentanyl addition. However, there is report where fen-
tanyl addition do not cause any change in the sedation
[10], however, similar to the findings of Randalls et. al
(1991) [10] we found significant reduction in the inci-
dence of nausea by the addition of fentanyl to bupi-
vacaine. Further, negligible incidences of pruritus,
shivering or respiratory depression were observed. Also,
the apgar score of the babies remained same in all the
groups. There was longer duration of postoperative anal-
gesia in fentanyl-bupivacaine groups; this also increases
with the increasing dose of bupivacaine. However, motor
recovery was not affected by the addition of fentanyl.
Conclusion
The above study can be concluded as bupivacaine -fenta-
nyl combination leads to abolishment of the visceral pain,
reduction in nausea incidence increased hemodynamic
stability and increases the duration of post-operative anal-
gesia; however no effect can be seen on bradycardia,
nausea, vomiting, shivering, maternal or neonatal respira-
tion. Thus, overall the combined effect of fentanyl-bupi-
vacaine is superior over just bupivacaine alone as fentanyl
apart from positive effects, retards the negativity as well as
reduces the doses of bupivacine too.
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